## Abstract In a large population‐based case–control study in Germany, including 3,464 breast cancer cases aged 50–74 at diagnosis and 6,657 population based and frequency matched controls, we investigated the effects of menopausal hormone therapy (HT) by type, regimen, timing and progestagenic con
Re: Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy
✍ Scribed by Martina Dören; Eberhard M. Greiser
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 37 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Letter to the Editor Reply to the letter to the editor by M. D€ oren and E.M. Greiser regarding the article ''Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy''
## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HT–BMI–breast cancer associations. We undertook a nested case
We examined the association between oral contraceptive use and risk of specific breast cancer histopathologies in a large, multi-center, population-based, case-control study. Women younger than age 75 with a new diagnosis of invasive breast cancer were identified from 4 statewide tumor registries. W
## Background: The incidence of invasive lobular carcinoma has been increasing among postmenopausal women in some parts of the united states. part of this may be due to changes in classification over time. however, the use of combined (estrogen and progestin) hormone replacement therapy (chrt) also
## Abstract Postmenopausal hormone therapy (HT) is associated with increased risk of breast cancer. The HTs used in Scandinavia is associated with higher risk estimates than those used in most other countries. Mammographic density is one of the strongest risk factors for breast cancer, and possibly